Cargando…

The Clinical and MRI Effect of TNF-α Inhibitors in Spondyloarthritis Patients With Hip Involvement: A Real-World Observational Clinical Study

OBJECTIVES: Hip involvement is an important cause of disability and poor prognosis in patients with spondyloarthritis (SpA). Tumor necrosis factor (TNF)-α inhibitor treatment has been demonstrated to be effective in SpA patients with hip arthritis; however, quantitative assessment using MRI in long-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Kui, Zheng, Yan, Han, Qing, Liu, Ying, Wang, Weitao, Ding, Jin, Wang, Yan, Zhang, Bei, Jia, Junfeng, Zheng, Minwen, Zheng, Zhaohui, Zhu, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511713/ https://www.ncbi.nlm.nih.gov/pubmed/34659233 http://dx.doi.org/10.3389/fimmu.2021.740980

Ejemplares similares

Deep-learning based quantification model for hip bone marrow edema and synovitis in patients with spondyloarthritis based on magnetic resonance images
por: Zheng, Yan, et al.
Publicado: (2023)

Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis
por: Hiltunen, J., et al.
Publicado: (2021)

Response to lower dose TNF inhibitors in axial spondyloarthritis; a real-world multicentre observational study
por: Van Rossen, Liz, et al.
Publicado: (2020)

TNF-α Promoter Polymorphisms Predict the Response to Etanercept More Powerfully than that to Infliximab/Adalimumab in Spondyloarthritis
por: Liu, Jing, et al.
Publicado: (2016)

Prediction of Treatment Response According to ASAS-EULAR Management Recommendations in 1 Year for Hip Involvement in Axial Spondyloarthritis Based on MRI and Clinical Indicators
por: Xie, Zhuoyao, et al.
Publicado: (2021)

Cardiovascular risk in patients with spondyloarthritis and association with anti-TNF drugs
por: Chan, Shirley Chiu Wai, et al.
Publicado: (2021)

A Real-World Study on the Effect of Imrecoxib for Patients with Axial Spondyloarthritis
por: Zong, He-xiang, et al.
Publicado: (2022)

Comparative Analysis of Clinical and Imaging Features of Osteomalacia and Spondyloarthritis
por: Zhao, Zheng, et al.
Publicado: (2021)

Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum
por: Sivera, Francisca, et al.
Publicado: (2023)

Clinical evaluation of covered stents in the treatment of superficial femoral artery pseudoaneurysm in drug abusers
por: Xu, Jian, et al.
Publicado: (2018)

Progressive pseudorheumatoid dysplasia involving a novel WISP3 mutation and sacroiliac and hip arthritis: A case report and literature review
por: Wang, Weitao, et al.
Publicado: (2023)

Effectiveness and safety of 12-month certolizumab pegol treatment for axial spondyloarthritis in real-world clinical practice in Europe
por: Baraliakos, Xenofon, et al.
Publicado: (2020)

Synthetic MRI in the detection and quantitative evaluation of sacroiliac joint lesions in axial spondyloarthritis
por: Zhang, Ke, et al.
Publicado: (2022)

Onset of lupus like syndrome in patients with spondyloarthritis treated with anti-TNF-α
por: Puertas-Abreu, Eduardo, et al.
Publicado: (2012)

Predictive Value of Active Sacroiliitis in MRI for Flare Among Chinese Patients with Axial Spondyloarthritis in Remission
por: Zheng, Qing, et al.
Publicado: (2021)

Case report: Kimura's disease with minimal degenerative glomerulopathy without eosinophil infiltration responds to mycophenolate mofetil treatment
por: Han, Qing, et al.
Publicado: (2023)

Gout mimicking spondyloarthritis: case report and literature review
por: Chen, Wenji, et al.
Publicado: (2017)

Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis
por: Hernández-Breijo, Borja, et al.
Publicado: (2019)

Clonorchis sinensis excretory/secretory products promote the secretion of TNF-alpha in the mouse intrahepatic biliary epithelial cells via Toll-like receptor 4
por: Yan, Chao, et al.
Publicado: (2015)

Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study
por: D’Angelo, Salvatore, et al.
Publicado: (2022)

Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNFα therapy
por: Aita, Ada, et al.
Publicado: (2018)

The Real-World Clinical Impact of Plasma mNGS Testing: an Observational Study
por: Han, Dongsheng, et al.
Publicado: (2023)

Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system
por: How Shing Koy, Elsa, et al.
Publicado: (2021)

Testing if Micro-CT Is Capable of Quantitating the Extent of Proteoglycan-Aggrecan Induced Axial Spondyloarthritis in Mice
por: Han, Qing, et al.
Publicado: (2021)

Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis
por: Paramarta, Jacqueline E, et al.
Publicado: (2011)

Relative overexpression of membrane-bound versus soluble TNF in spondyloarthritis
por: Ambarus, Carmen A, et al.
Publicado: (2012)

Investigation and Analysis of Anxiety and Quality of Life among Systemic Lupus Erythematosus Patients in Northwestern China
por: Wang, Qing, et al.
Publicado: (2022)

Automated detection of hippocampal sclerosis using real-world clinical MRI images
por: Jiang, Jingwen, et al.
Publicado: (2023)

Spondyloarthritis - the clinical picture in children
por: Vargas, Ruben Burgos
Publicado: (2014)

A small-scale, exploratory real-world study of nab-paclitaxel combined with oxaliplatin and tegafur in the perioperative treatment of advanced gastric cancer: a study protocol for a real-world clinical trial
por: Zheng, Jiyang, et al.
Publicado: (2023)

Common incidental findings on sacroiliac joint MRI in children clinically suspected of juvenile spondyloarthritis
por: Schiettecatte, E., et al.
Publicado: (2020)

Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China
por: Li, Kun-Peng, et al.
Publicado: (2018)

Ulcerative Colitis-associated Spondyloarthritis Successfully Treated with Infliximab in the Absence of Enhanced TNF-α Responses
por: Fujita, Shunsuke, et al.
Publicado: (2022)

Patients with Axial Spondyloarthritis Are at Risk of Developing Adhesive Capsulitis: Real-World Evidence Database Study in Taiwan
por: Huang, Shih-Wei, et al.
Publicado: (2020)

A Comprehensive Assessment of Hip Damage in Ankylosing Spondylitis, Especially Early Features
por: Han, Qing, et al.
Publicado: (2021)

Disease activity in axial spondyloarthritis after discontinuation of TNF inhibitors therapy
por: Sebastian, Agata, et al.
Publicado: (2017)

Transmembrane TNF drives osteoproliferative joint inflammation reminiscent of human spondyloarthritis
por: Kaaij, Merlijn H., et al.
Publicado: (2020)

Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis
por: Ditto, Maria Chiara, et al.
Publicado: (2021)

Comorbidity and response to TNF inhibitors in axial spondyloarthritis: longitudinal analysis of the BSRBR-AS
por: Zhao, Sizheng Steven, et al.
Publicado: (2020)

A real-world clinical validation for AI-based MRI monitoring in multiple sclerosis
por: Barnett, Michael, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lvv8df527qhou0c4h2d18s6tl9